Your browser doesn't support javascript.
loading
Comparison of cryoprotectants in hematopoietic cell infusion-related adverse events.
Ikeda, Kazuhiko; Minakawa, Keiji; Yamahara, Kenichi; Yamada-Fujiwara, Minami; Okuyama, Yoshiki; Fujiwara, Shin-Ichiro; Yamazaki, Rie; Kanamori, Heiwa; Iseki, Tohru; Nagamura-Inoue, Tokiko; Kameda, Kazuaki; Nagai, Kazuhiro; Fujii, Nobuharu; Ashida, Takashi; Hirose, Asao; Takahashi, Tsutomu; Ohto, Hitoshi; Ueda, Koki; Tanosaki, Ryuji.
Affiliation
  • Ikeda K; Cell Therapy Committee, Japan Society of Transfusion Medicine and Cell Therapy, Tokyo, Japan.
  • Minakawa K; Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Yamahara K; Cell Therapy Committee, Japan Society of Transfusion Medicine and Cell Therapy, Tokyo, Japan.
  • Yamada-Fujiwara M; Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Okuyama Y; Laboratory of Medical Innovation, Institute for Advanced Medical Sciences, Hyogo College of Medicine, Nishinomiya, Japan.
  • Fujiwara SI; Cell Therapy Committee, Japan Society of Transfusion Medicine and Cell Therapy, Tokyo, Japan.
  • Yamazaki R; Division of Blood Transfusion and Cell Therapy, Tohoku University Hospital, Sendai, Japan.
  • Kanamori H; Cell Therapy Committee, Japan Society of Transfusion Medicine and Cell Therapy, Tokyo, Japan.
  • Iseki T; Division of Transfusion and Cell Therapy, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan.
  • Nagamura-Inoue T; Cell Therapy Committee, Japan Society of Transfusion Medicine and Cell Therapy, Tokyo, Japan.
  • Kameda K; Division of Cell Transplantation and Transfusion, Jichi Medical University Hospital, Shimotsuke, Japan.
  • Nagai K; Center for Transfusion Medicine and Cell Therapy, Keio University School of Medicine, Tokyo, Japan.
  • Fujii N; Cell Therapy Committee, Japan Society of Transfusion Medicine and Cell Therapy, Tokyo, Japan.
  • Ashida T; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
  • Hirose A; Cell Therapy Committee, Japan Society of Transfusion Medicine and Cell Therapy, Tokyo, Japan.
  • Takahashi T; Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Chiba, Japan.
  • Ohto H; Cell Therapy Committee, Japan Society of Transfusion Medicine and Cell Therapy, Tokyo, Japan.
  • Ueda K; Institution of Medical Science, University of Tokyo, Tokyo, Japan.
  • Tanosaki R; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Transfusion ; 62(6): 1280-1288, 2022 06.
Article in En | MEDLINE | ID: mdl-35396716
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Dimethyl Sulfoxide / Hematopoietic Stem Cell Transplantation Type of study: Observational_studies / Risk_factors_studies Limits: Animals / Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Dimethyl Sulfoxide / Hematopoietic Stem Cell Transplantation Type of study: Observational_studies / Risk_factors_studies Limits: Animals / Humans Language: En Year: 2022 Type: Article